📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Enhancement by pyrazolones of colistin efficacy against mcr-1-expressing E. coli: an in silico and in vitro investigation. (2023)

First Author: Hanpaibool C

Attributed to: Nicotinic Ligand Development to Target Smoking Cessation and Gain a Molecular Level Understanding of Partial Agonism funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10822-023-00519-z

PubMed Identifier: 37488458

Publication URI: http://europepmc.org/abstract/MED/37488458

Type: Journal Article/Review

Volume: 37

Parent Publication: Journal of computer-aided molecular design

Issue: 10

ISSN: 0920-654X